- Home
- ALLO vs OFLX Comparison
ALLO vs OFLX Comparison
Compare ALLO & OFLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALLO
- OFLX
- Stock Information
- Founded
- ALLO 2017
- OFLX 1975
- Country
- ALLO United States
- OFLX United States
- Employees
- ALLO N/A
- OFLX N/A
- Industry
- ALLO Biotechnology: Biological Products (No Diagnostic Substances)
- OFLX Industrial Specialties
- Sector
- ALLO Health Care
- OFLX Industrials
- Exchange
- ALLO Nasdaq
- OFLX Nasdaq
- Market Cap
- ALLO 438.2M
- OFLX 423.7M
- IPO Year
- ALLO 2018
- OFLX 2005
- Fundamental
- Price
- ALLO $1.92
- OFLX $41.24
- Analyst Decision
- ALLO Strong Buy
- OFLX
- Analyst Count
- ALLO 10
- OFLX 0
- Target Price
- ALLO $10.06
- OFLX N/A
- AVG Volume (30 Days)
- ALLO 3.0M
- OFLX 22.9K
- Earning Date
- ALLO 11-07-2024
- OFLX 03-05-2025
- Dividend Yield
- ALLO N/A
- OFLX 3.37%
- EPS Growth
- ALLO N/A
- OFLX N/A
- EPS
- ALLO N/A
- OFLX 1.81
- Revenue
- ALLO $43,000.00
- OFLX $102,863,000.00
- Revenue This Year
- ALLO N/A
- OFLX N/A
- Revenue Next Year
- ALLO N/A
- OFLX N/A
- P/E Ratio
- ALLO N/A
- OFLX $22.20
- Revenue Growth
- ALLO 26.47
- OFLX N/A
- 52 Week Low
- ALLO $1.78
- OFLX $37.27
- 52 Week High
- ALLO $5.78
- OFLX $76.50
- Technical
- Relative Strength Index (RSI)
- ALLO 39.98
- OFLX 42.54
- Support Level
- ALLO $2.11
- OFLX $37.27
- Resistance Level
- ALLO $2.40
- OFLX $42.94
- Average True Range (ATR)
- ALLO 0.17
- OFLX 1.50
- MACD
- ALLO 0.00
- OFLX 0.08
- Stochastic Oscillator
- ALLO 15.79
- OFLX 67.29
About ALLO Allogene Therapeutics Inc.
Allogene Therapeutics Inc is a clinical-stage biotech firm specializing in immuno-oncology, focusing on the development of genetically engineered allogeneic T-cell products for cancer and autoimmune diseases. Their pipeline includes off-the-shelf T-cell candidates designed to target cancer cells or autoreactive cells in autoimmune disorders. Notably, their allogeneic approach, derived from healthy donors, allows for broader patient eligibility and scalability. With a vision to redefine CAR T therapy, the company concentrates on core programs targeting lymphoma, leukemia, autoimmune diseases, and solid tumors. Revenue, primarily generated from collaborations and licensing agreements, supports their research and development efforts.
About OFLX Omega Flex Inc.
Omega Flex Inc is a manufacturer of flexible metal hoses, which is used in a variety of ways to carry gases and liquids within their particular applications. Omega sells its products under the TracPipe, CounterStrike, DoubleTrac, DEF-Trac and MediTrac brands. It serves various markets which include construction, manufacturing, transportation, petrochemical, pharmaceutical, and other industries. Geographically Omega Flex, Inc operates in the United States.